APA

Theisen M., Dodoo D., Toure-Balde A., Soe S., Corradin G., Koram K. K., Kurtzhals J. A., Hviid L., Theander T., Akanmori B., Ndiaye M. & Druilhe P. (20010913). Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. : Infection and immunity.

Chicago

Theisen M, Dodoo D, Toure-Balde A, Soe S, Corradin G, Koram K K, Kurtzhals J A, Hviid L, Theander T, Akanmori B, Ndiaye M and Druilhe P. 20010913. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. : Infection and immunity.

Harvard

Theisen M., Dodoo D., Toure-Balde A., Soe S., Corradin G., Koram K. K., Kurtzhals J. A., Hviid L., Theander T., Akanmori B., Ndiaye M. and Druilhe P. (20010913). Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. : Infection and immunity.

MLA

Theisen M, Dodoo D, Toure-Balde A, Soe S, Corradin G, Koram K K, Kurtzhals J A, Hviid L, Theander T, Akanmori B, Ndiaye M and Druilhe P. Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. : Infection and immunity. 20010913.